Components:
Treatment option:
Medically reviewed by Militian Inessa Mesropovna, PharmD. Last updated on 26.06.2023
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Name of the medicinal product
Adenyl
Qualitative and quantitative composition
Adenosine Phosphate
Therapeutic indications
Acute traveling porphyria, lead poisoning, chronic obliterating endarteritis, thrombophlebitis, chronic venous insufficiency, venous thrombosis, CHD, diabetic retinopathy, duodenal ulcer, multiple sclerosis.
Dosage (Posology) and method of administration
Inside. In acute porphyria and diabetic retinopathy-0.05 g 2 times a day, for a long time, in peripheral vascular diseases — 0.05 g 2-3 times a day, in chronic ischemic heart disease — 0.05 g 4 times a day, in other diseases — 0.025–0.05 g (up to 0.15 g) per day.
Undesirable effects
Nausea, dizziness, allergic reactions.
Pharmacotherapeutic group
- Other metabolites
